<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3571</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.SP193</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>A Survey on Coronavirus Vaccination&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Vijay</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Shipra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kalra</surname><given-names>Jasmeet</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>Shipra</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>03</month><year>2021</year></pub-date><volume>rn</volume><issue>ch</issue><fpage>97</fpage><lpage>103</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: Right now many pharmaceutical companies are tried to finalise the vaccines of coronavirus and many are trying. In India, vaccination of coronavirus is the world__ampersandsignrsquo;s largest program. Many types of rumours are coming from the side of the public of the whole world about the vaccination. The authors are decided to survey in this regard. Objective: To investigate immunization trust in locally made coronavirus antibodies and antibody inclination. Methods: In December 2020, the authors are surveyed 500 people of the top ten states of India about the acceptance rates and factors influencing acceptance of a coronavirus vaccine. For this survey, online platform technology is used to find the response of the participants. Results: The results of the survey represent that out of 500 respondents, 53.5% were females. 37.6% of people were responded who have an income level of Rs. 501-1000 per day. 38.8% of those people responded who have an only intermediate qualifi cation. 42.4% of people having the age group 25 to 54 years were responded to the vaccination survey. 51.8% of people fully agreed with vaccination but 34% of people suggested if it is coming from the side of the employer, it becomes more successful. Conclusion: By survey analysis of this paper, it is concluded that maximum people are trusting and some are not agreed with the vaccination.&#13;
</p></abstract><kwd-group><kwd> Coronavirus</kwd><kwd> Vaccination</kwd><kwd> Survey</kwd><kwd> Respondent’s perception</kwd><kwd> Behaviour study</kwd></kwd-group></article-meta></front></article>
